Prognostic Value of Subfamily Gene Expression in Cholangiocarcinoma

Overview

Journal World J Gastrointest Oncol

Publisher Baishideng Publishing Group

Date 2024 Oct 1

PMID 39350976

Authors

Li Wang

Zhe Zhang

Hai-Zhang Ma

Affiliations

Soon will be listed here.

Abstract

Background: Cholangiocarcinoma (CCA) is a lethal malignancy with limited treatment options and poor prognosis. The subfamily of E26 transformation specific genes: , , and are known to play significant roles in various cancers by influencing cell proliferation, invasion, and metastasis.

Aim: To analyze subfamily gene expression levels in CCA and their correlation with clinical parameters to determine their prognostic value for CCA.

Methods: The expression levels of subfamily genes in pan-cancer and CCA data in the cancer genome atlas and genotype-tissue expression project databases were analyzed with R language software. Survival curve and receiver operating characteristic analyses were performed using the SurvMiner, Survival, and Procr language packages. The gene expression profiling interactive analysis 2.0 database was used to analyze the expression levels of subfamily genes in different subtypes and stages of CCA. Web Gestalt was used to perform the gene ontology/ Kyoto encyclopedia of genes and genomes (GO/KEGG) analysis, and STRING database analysis was used to determine the genes and proteins related to subfamily genes.

Results: , , and expression levels were significantly increased in CCA. There were significant differences in , , and expression levels among the different subtypes of CCA, and predictive analysis revealed that only high and expression levels were significantly associated with shorter overall survival in patients with CCA. GO/KEGG analysis revealed that subfamily genes were closely related to transcriptional misregulation in cancer. and experiments revealed that silencing inhibited the invasion and metastasis of CCA cells.

Conclusion: The expression level of may be a predictive biomarker of survival in patients with CCA.

Citing Articles

Elevated expression in cholangiocarcinoma is linked to poor prognosis and may guide targeted therapies.

Okpete U, Byeon H World J Gastrointest Oncol. 2024; 16(11):4528-4531.

PMID: 39554735 PMC: 11551638. DOI: 10.4251/wjgo.v16.i11.4528.

References

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Singsuksawat E, Thuwajit C, Charngkaew K, Thuwajit P . Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells. Cancer Cell Int. 2018; 18:25. PMC: 5819217. DOI: 10.1186/s12935-018-0525-z. View

Jung M, Park S, Jeon Y, Won J, Yang H, Kim W . Gastrointestinal stromal tumor of unusual phenotype after imatinib treatment: A case report and diagnostic utility of ETV1 mRNA in situ hybridization. Medicine (Baltimore). 2017; 96(49):e9031. PMC: 5728909. DOI: 10.1097/MD.0000000000009031. View

Jong M, Marques H, Clary B, Bauer T, Marsh J, Ribero D . The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer. 2012; 118(19):4737-47. DOI: 10.1002/cncr.27492. View

Currie S, Lau D, Doane J, Whitby F, Okon M, McIntosh L . Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5. Nucleic Acids Res. 2017; 45(5):2223-2241. PMC: 5389675. DOI: 10.1093/nar/gkx068. View

Fontanet P, Irala D, Alsina F, Paratcha G, Ledda F . Pea3 transcription factor family members Etv4 and Etv5 mediate retrograde signaling and axonal growth of DRG sensory neurons in response to NGF. J Neurosci. 2013; 33(40):15940-51. PMC: 6618483. DOI: 10.1523/JNEUROSCI.0928-13.2013. View

Zhang X, Wei R, Sun Y, Xia Q, Xie W, Song H . AKT3 Is a Pivotal Molecule of Cadherin-22 and GDNF Family Receptor-α1 Signal Pathways Regulating Self-Renewal in Female Germline Stem Cells. Stem Cells. 2019; 37(8):1095-1107. DOI: 10.1002/stem.3030. View

Cooper C, Newman J, Aitkenhead H, Allerston C, Gileadi O . Structures of the Ets Protein DNA-binding Domains of Transcription Factors Etv1, Etv4, Etv5, and Fev: DETERMINANTS OF DNA BINDING AND REDOX REGULATION BY DISULFIDE BOND FORMATION. J Biol Chem. 2015; 290(22):13692-709. PMC: 4447949. DOI: 10.1074/jbc.M115.646737. View

Kim E, Kim D, Lee J, Yoe J, Park J, Kim C . Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis. Hepatology. 2017; 67(6):2287-2301. DOI: 10.1002/hep.29738. View

10.

Chen Y, Sumardika I, Tomonobu N, Kinoshita R, Inoue Y, Iioka H . Critical role of the MCAM-ETV4 axis triggered by extracellular S100A8/A9 in breast cancer aggressiveness. Neoplasia. 2019; 21(7):627-640. PMC: 6520639. DOI: 10.1016/j.neo.2019.04.006. View

11.

Zhang X, Wang Y, Liu X, Zhao A, Yang Z, Kong F . KIF2A promotes the progression via AKT signaling pathway and is upregulated by transcription factor ETV4 in human gastric cancer. Biomed Pharmacother. 2020; 125:109840. DOI: 10.1016/j.biopha.2020.109840. View

12.

Yang Q, Zhong S, He L, Jia X, Tang H, Cheng S . PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway. Cancer Lett. 2019; 452:90-102. DOI: 10.1016/j.canlet.2019.03.028. View

13.

Zhou Y, Wang M, Shuang T, Liu Y, Zhang Y, Shi C . MiR-1307 influences the chemotherapeutic sensitivity in ovarian cancer cells through the regulation of the CIC transcriptional repressor. Pathol Res Pract. 2019; 215(10):152606. DOI: 10.1016/j.prp.2019.152606. View

14.

Liao Y, Wang J, Jaehnig E, Shi Z, Zhang B . WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019; 47(W1):W199-W205. PMC: 6602449. DOI: 10.1093/nar/gkz401. View

15.

Zhao L, Sun X, Chen L, Feng X, Yang X, Zou P . Hepatitis C Virus Core Protein Promotes the Metastasis of Human Hepatocytes by Activating the MAPK/ERK/PEA3-SRF/c-Fos/MMPs Axis. Arch Med Res. 2022; 53(5):469-482. DOI: 10.1016/j.arcmed.2022.06.004. View

16.

Nassour I, Mokdad A, Porembka M, Choti M, Polanco P, Mansour J . Adjuvant Therapy Is Associated With Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study. Ann Surg Oncol. 2018; 25(5):1193-1201. DOI: 10.1245/s10434-018-6388-7. View

17.

Chen Z, Liu G, Hossain A, Danilova I, Bolkov M, Liu G . A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival. Hereditas. 2019; 156:24. PMC: 6617625. DOI: 10.1186/s41065-019-0100-1. View

18.

Qi T, Qu Q, Li G, Wang J, Zhu H, Yang Z . Function and regulation of the PEA3 subfamily of ETS transcription factors in cancer. Am J Cancer Res. 2020; 10(10):3083-3105. PMC: 7642666. View

19.

Eskandari E, Mahjoubi F, Motalebzadeh J . An integrated study on TFs and miRNAs in colorectal cancer metastasis and evaluation of three co-regulated candidate genes as prognostic markers. Gene. 2018; 679:150-159. DOI: 10.1016/j.gene.2018.09.003. View

20.

Vivian J, Rao A, Nothaft F, Ketchum C, Armstrong J, Novak A . Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017; 35(4):314-316. PMC: 5546205. DOI: 10.1038/nbt.3772. View